During the past decade, Malawi CRS conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Malawi CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "HIV Prevention Trials Network" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "ViiV Healthcare" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Malawi CRS" are "HIV Infections" (10 trials), "Tuberculosis" (4 trials), "COVID-19" (3 trials), "HIV Infection" (3 trials) and "SARS-CoV-2" (2 trials). Many other conditions were trialed in "Malawi CRS" in a lesser frequency.

Most popular intervention types in "Malawi CRS" are "Drug" (13 trials), "Dietary Supplement" (4 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Isoniazid (INH)" (5 trials), "Rifapentine (RPT)" (4 trials), "VRC01" (3 trials), "Dolutegravir (DTG)" (2 trials) and "Pyrazinamide (PZA)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Malawi CRS" are 14 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Malawi CRS". 1 are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Malawi CRS, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Malawi CRS, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".